Hartmut Koeppen

1988–2025 年に発表

114
論文数
38,863
被引用数
84
h 指数
112
i10 指数

被引用数

Hartmut Koeppen の年別被引用数1945 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 9 件1991 年: 被引用 11 件1992 年: 被引用 11 件1993 年: 被引用 19 件1994 年: 被引用 10 件1995 年: 被引用 18 件1996 年: 被引用 10 件1997 年: 被引用 28 件1998 年: 被引用 25 件1999 年: 被引用 34 件2000 年: 被引用 69 件2001 年: 被引用 84 件2002 年: 被引用 84 件2003 年: 被引用 125 件2004 年: 被引用 130 件2005 年: 被引用 152 件2006 年: 被引用 167 件2007 年: 被引用 165 件2008 年: 被引用 201 件2009 年: 被引用 166 件2010 年: 被引用 216 件2011 年: 被引用 185 件2012 年: 被引用 261 件2013 年: 被引用 355 件2014 年: 被引用 342 件2015 年: 被引用 499 件2016 年: 被引用 539 件2017 年: 被引用 517 件2018 年: 被引用 592 件2019 年: 被引用 1,543 件2020 年: 被引用 1,827 件2021 年: 被引用 1,961 件2022 年: 被引用 1,694 件2023 年: 被引用 1,311 件2024 年: 被引用 1,848 件2025 年: 被引用 982 件2026 年: 被引用 30 件1946〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,464 件、この内訳の 27.4%中国: 引用元論文 3,767 件、この内訳の 16%イギリス: 引用元論文 1,277 件、この内訳の 5.4%ドイツ: 引用元論文 1,209 件、この内訳の 5.1%フランス: 引用元論文 1,021 件、この内訳の 4.3%イタリア: 引用元論文 942 件、この内訳の 4%日本: 引用元論文 890 件、この内訳の 3.8%スペイン: 引用元論文 696 件、この内訳の 3%カナダ: 引用元論文 605 件、この内訳の 2.6%オランダ: 引用元論文 586 件、この内訳の 2.5%オーストラリア: 引用元論文 577 件、この内訳の 2.4%スイス: 引用元論文 566 件、この内訳の 2.4%
0%27.4%その他 21.1%

分野

  • Medicine58.3%
  • Biochemistry, Genetics and Molecular Biology28.9%
  • Immunology and Microbiology8.6%
  • Engineering1.1%
  • Neuroscience0.9%
  • Computer Science0.7%
  • その他1.5%

トピック

  • Cancer Immunotherapy and Biomarkers11.1%
  • Immunotherapy and Immune Responses4.5%
  • CAR-T cell therapy research3.2%
  • Cancer Cells and Metastasis3.1%
  • Immune cells in cancer2.9%
  • Immune Cell Function and Interaction2.8%
  • その他72.4%

共著者

全論文

検索で開く
  1. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michiel S. van der Heijden, Yohann Loriot, Jonathan E. Rosenberg, Lawrence Fong, Ira Mellman, Daniel S. Chen, Marjorie Green, Christina Louise Derleth, Gregg Fine, Priti S. Hegde, Richard Bourgon, Thomas Powles - Nature 2018 被引用: 5,616

  2. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature 2014 被引用: 5,302

  3. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy

    著者: , , , , , , , , , , , , , , , , - Cancer Discovery 2019 被引用: 846

  4. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 627

  5. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2022 被引用: 403

  6. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer

    著者: , , , , , , , , , , , , - Nature 2017 被引用: 803

  7. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

    著者: , , , , , , , , , , , , , , , , - Cancer Research 2008 被引用: 1,678

  8. Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

    著者: , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 被引用: 561

  9. High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2020 被引用: 439

  10. CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ira Mellman, Shannon J. Turley, Mark S. Wilson, Sanjeev Mariathasan, Luciana Molinero, Mark Merchant, Nathaniel R. West - Cell Reports Medicine 2023 被引用: 183

  11. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  12. Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 129

  13. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marileila Varella‐Garcia, Adi F. Gazdar, Frédéric J. de Sauvage, Richard Bourgon, John D. Minna, Malcolm V. Brock, Somasekar Seshagiri - Nature Genetics 2012 被引用: 1,098

  14. Integrated digital pathology and transcriptome analysis identifies molecular mediators of T-cell exclusion in ovarian cancer

    著者: , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 207

  15. Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2024 被引用: 157

  16. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

    著者: , , , , , , , , , , , , , , , , , , , , - Nature 2010 被引用: 1,638

  17. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  18. Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 被引用: 713

  19. Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2022 被引用: 127

  20. Recurrent R-spondin fusions in colon cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2012 被引用: 982

  21. Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2021 被引用: 147

  22. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Research 2020 被引用: 87

  23. Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , - Blood 2009 被引用: 271

  24. Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2017 被引用: 364